Home UPDATE 1-U.S. health insurers say Gilead hepatitis C drug too costly
 

Keywords :   


UPDATE 1-U.S. health insurers say Gilead hepatitis C drug too costly

2014-05-21 03:50:55| Biotech - Topix.net

The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels.

Tags: health too update drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Weekly Recap: PPG, Axalta, AkzoNobel Top This Weeks Stories
21.09Atlantic Tropical Weather Outlook
More »